144 related articles for article (PubMed ID: 20564833)
1. Identification of candidate genes with pro-apoptotic properties by functional screening of randomly fragmented cDNA libraries.
Hassan M; Matuschek C; Gerber PA; Peiper M; Budach W; Bölke E
Eur J Med Res; 2010 Apr; 15(4):162-8. PubMed ID: 20564833
[TBL] [Abstract][Full Text] [Related]
2. Identification of functional genes during Fas-mediated apoptosis using a randomly fragmented cDNA library.
Hassan M; Mirmohammadsadegh A; Selimovic D; Nambiar S; Tannapfel A; Hengge UR
Cell Mol Life Sci; 2005 Sep; 62(17):2015-26. PubMed ID: 16091844
[TBL] [Abstract][Full Text] [Related]
3. A functional gene discovery in the Fas-mediated pathway to apoptosis by analysis of transiently expressed randomized hybrid-ribozyme libraries.
Kawasaki H; Taira K
Nucleic Acids Res; 2002 Aug; 30(16):3609-14. PubMed ID: 12177303
[TBL] [Abstract][Full Text] [Related]
4. Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA library.
Li Z; Stanelle J; Leurs C; Hanenberg H; Pützer BM
Nucleic Acids Res; 2005; 33(9):2813-21. PubMed ID: 15897325
[TBL] [Abstract][Full Text] [Related]
5. Identification of genes that function in the TNF-alpha-mediated apoptotic pathway using randomized hybrid ribozyme libraries.
Kawasaki H; Onuki R; Suyama E; Taira K
Nat Biotechnol; 2002 Apr; 20(4):376-80. PubMed ID: 11923844
[TBL] [Abstract][Full Text] [Related]
6. Candidate tumour suppressor LUCA-15 can regulate multiple apoptotic pathways.
Mourtada-Maarabouni M; Sutherland LC; Williams GT
Apoptosis; 2002 Oct; 7(5):421-32. PubMed ID: 12207175
[TBL] [Abstract][Full Text] [Related]
7. A functional yeast survival screen of tumor-derived cDNA libraries designed to identify anti-apoptotic mammalian oncogenes.
Eißmann M; Schwamb B; Melzer IM; Moser J; Siele D; Köhl U; Rieker RJ; Wachter DL; Agaimy A; Herpel E; Baumgarten P; Mittelbronn M; Rakel S; Kögel D; Böhm S; Gutschner T; Diederichs S; Zörnig M
PLoS One; 2013; 8(5):e64873. PubMed ID: 23717670
[TBL] [Abstract][Full Text] [Related]
8. Death-associated proteins: from gene identification to the analysis of their apoptotic and tumour suppressive functions.
Kissil JL; Kimchi A
Mol Med Today; 1998 Jun; 4(6):268-74. PubMed ID: 9679246
[TBL] [Abstract][Full Text] [Related]
9. NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis.
Kühnel F; Zender L; Paul Y; Tietze MK; Trautwein C; Manns M; Kubicka S
J Biol Chem; 2000 Mar; 275(9):6421-7. PubMed ID: 10692445
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD95(FAS) by gene transfer does not sensitize K562 to Fas-killing.
Munker R; Marini F; Jiang S; Savary C; Owen-Schaub L; Andreeff M
Hematol Cell Ther; 1997 Apr; 39(2):75-8. PubMed ID: 9168303
[TBL] [Abstract][Full Text] [Related]
11. Frequency and resistance of CD95 (Fas/Apo-1) gene-transfected tumor cells to CD95-mediated apoptosis by the elimination and methylation of integrated DNA.
Shimizu M; Yoshimoto T; Sato M; Matsuzawa A; Takeda Y
Int J Cancer; 2006 Aug; 119(3):585-92. PubMed ID: 16506211
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells.
Strand S; Vollmer P; van den Abeelen L; Gottfried D; Alla V; Heid H; Kuball J; Theobald M; Galle PR; Strand D
Oncogene; 2004 Apr; 23(20):3732-6. PubMed ID: 15077180
[TBL] [Abstract][Full Text] [Related]
13. CD95 promotes tumour growth.
Chen L; Park SM; Tumanov AV; Hau A; Sawada K; Feig C; Turner JR; Fu YX; Romero IL; Lengyel E; Peter ME
Nature; 2010 May; 465(7297):492-6. PubMed ID: 20505730
[TBL] [Abstract][Full Text] [Related]
14. Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95.
Re D; Hofmann A; Wolf J; Diehl V; Staratschek-Jox A
Exp Hematol; 2000 Jan; 28(1):31-5. PubMed ID: 10658674
[TBL] [Abstract][Full Text] [Related]
15. Clonal variability in CD95 expression is the major determinant in Fas-medicated, but not chemotherapy-medicated apoptosis in the RPMI 8226 multiple myeloma cell line.
Shain KH; Landowski TH; Buyuksal I; Cantor AB; Dalton WS
Leukemia; 2000 May; 14(5):830-40. PubMed ID: 10803514
[TBL] [Abstract][Full Text] [Related]
16. Identification of SNF1/AMP kinase-related kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness.
Legembre P; Schickel R; Barnhart BC; Peter ME
J Biol Chem; 2004 Nov; 279(45):46742-7. PubMed ID: 15345718
[TBL] [Abstract][Full Text] [Related]
17. Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatment.
Bagnoli M; Balladore E; Luison E; Alberti P; Raspagliesi F; Marcomini B; Canevari S; Mezzanzanica D
Mol Cancer Ther; 2007 Feb; 6(2):762-72. PubMed ID: 17308072
[TBL] [Abstract][Full Text] [Related]
18. Mutations in apoptosis genes: a pathogenetic factor for human disease.
Müllauer L; Gruber P; Sebinger D; Buch J; Wohlfart S; Chott A
Mutat Res; 2001 Jul; 488(3):211-31. PubMed ID: 11397650
[TBL] [Abstract][Full Text] [Related]
19. CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage.
Raats DA; Frenkel N; van Schelven SJ; Rinkes IH; Laoukili J; Kranenburg O
Cell Death Dis; 2017 Mar; 8(3):e2669. PubMed ID: 28300842
[TBL] [Abstract][Full Text] [Related]
20. 3D Cellular Architecture Modulates Tyrosine Kinase Activity, Thereby Switching CD95-Mediated Apoptosis to Survival.
Gülcüler Balta GS; Monzel C; Kleber S; Beaudouin J; Balta E; Kaindl T; Chen S; Gao L; Thiemann M; Wirtz CR; Samstag Y; Tanaka M; Martin-Villalba A
Cell Rep; 2019 Nov; 29(8):2295-2306.e6. PubMed ID: 31747602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
